Nasdaq · CIK 0001479681
NUTX Nutex Health Inc.
Insider trading from SEC Form 4. Last filing 25 d ago. Close $206.29 on Oct 9, 2026, +137% from the 52-week low and -8% from the high.
In brief
Nutex Health Inc. (NUTX) has 37 SEC Form 4 filings on file from 13 insiders, the latest filed on Sep 18, 2026. In the last 90 days insiders made 0 open-market buys worth $0 and 1 open-market sell worth $43k, net -$43k.
7 open-market trades have been scored at NUTX. The newest: Scott J Saunders (director) sold $43k of stock on Sep 18, 2026, filed Sep 18, 2026, scored 31 (weak). The largest of the 7 shown: Jon Christian Bates (Chief Financial Officer) bought $103k on Nov 25, 2025, scored 43 (moderate). 4 insiders bought within 14 days of each other around Mar 19, 2026.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Nutex Health Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | Scott J Saunders director sell | $43k 203 shares | -34% | - | |
| 43Moderate | Warren Hosseinion President buy | $24k 252 shares | +3% | +101% from low-50% from high | |
| 46Moderate | Frank E Jaumot director buy | $14k 150 shares | - | +89% from low-53% from high | |
| 33Weak | Kelvin Spears director buy | $945 10 shares | +0% | +100% from low-51% from high | |
| 38Weak | Pamela W. Montgomery Chief Legal Officer-Healthcare buy | $7,021 79 shares | +3% | +94% from low-53% from high | |
| 43Moderate | Jon Christian Bates Chief Financial Officer buy | $103k 750 shares | +15% | +306% from low-33% from high | |
| 37Weak | Jon Christian Bates Chief Financial Officer buy | $82k 1,000 shares | +26% | +359% from low0% from high |
Transactions
The newest 50 of 73 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Scott J Saunders director | SOpen-market sale Common Stock | -203 | $214.25 | $43k | 400 | 25 d ago |
| Jul 31, 2026 | Scott J Saunders director | MOption exercise Common Stock | +603 | $0.00 | $0 | 603 | Aug 3, 2026 |
| Jul 31, 2026 | Michael Lee Reed director | MOption exercise Common Stockindirect: See note (2) | +603 | $0.00 | $0 | 670 | Aug 3, 2026 |
| Jul 31, 2026 | Frank E Jaumot director | MOption exercise Common Stock | +603 | $0.00 | $0 | 753 | Aug 3, 2026 |
| Jul 31, 2026 | Cheryl Yvonne Grenas director | MOption exercise Common Stock | +603 | $0.00 | $0 | 670 | Aug 3, 2026 |
| Jun 4, 2026 | Kelvin Spears director | JOther Common Stock | +2,519 | $0.00 | $0 | 34,656 | Jun 4, 2026 |
| May 28, 2026 | Thomas T. Vo Chief Executive Officer | JOther Common Stockindirect: By Micro Hospital Holdings LLC | +75,747 | $0.00 | $0 | 2,103,014 | May 29, 2026 |
| Apr 23, 2026 | Frank E Jaumot director | AGrant or award Restricted Stock Units (RSUs)derivative | +823 | $0.00 | $0 | 1,426 | Apr 24, 2026 |
| Apr 23, 2026 | Cheryl Yvonne Grenas director | AGrant or award Restricted Stock Units (RSUs)derivative | +823 | $0.00 | $0 | 1,426 | Apr 24, 2026 |
| Apr 23, 2026 | Michael Lee Reed director | AGrant or award Restricted Stock Units (RSUs)derivative | +823 | $0.00 | $0 | 1,426 | Apr 24, 2026 |
| Apr 23, 2026 | Scott J Saunders director | AGrant or award Restricted Stock Units (RSUs)derivative | +823 | $0.00 | $0 | 1,426 | Apr 24, 2026 |
| Apr 9, 2026 | Thomas T. Vo Chief Executive Officer | JOther Common Stockindirect: By Micro Hospital Holdings LLC | +184,071 | $0.00 | $0 | 2,027,267 | Apr 10, 2026 |
| Mar 10, 2026 | Thomas T. Vo Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | +4,841 | $0.00 | $0 | 16,507 | Apr 10, 2026 |
| Mar 11, 2026 | Wesley Shane Bamburg Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative | +2,411 | $0.00 | $0 | 2,411 | Mar 24, 2026 |
| Mar 20, 2026 | Frank E Jaumot director | POpen-market purchase Common Stock | +150 | $93.56 | $14k | 150 | Mar 23, 2026 |
| Mar 19, 2026 | Warren Hosseinion President | POpen-market purchase Common Stock | +252 | $94.07 | $24k | 7,765 | Mar 23, 2026 |
| Mar 10, 2026 | Warren Hosseinion President | MOption exercise Restricted Stock Unitsderivative | +3,656 | $0.00 | $0 | 12,465 | Mar 23, 2026 |
| Mar 17, 2026 | Kelvin Spears director | POpen-market purchase Common Stock | +10 | $94.46 | $945 | 32,137 | Mar 18, 2026 |
| Mar 10, 2026 | Kelvin Spears director | MOption exercise Restricted Stock Unitderivative | +116 | $0.00 | $0 | 339 | Mar 18, 2026 |
| Mar 13, 2026 | Pamela W. Montgomery Chief Legal Officer-Healthcare | POpen-market purchase Common Stock | +79 | $88.87 | $7,021 | 2,758 | Mar 16, 2026 |
| Mar 10, 2026 | Pamela W. Montgomery Chief Legal Officer-Healthcare | MOption exercise Restricted Stock Unitderivative | +1,523 | $0.00 | $0 | 4,441 | Mar 16, 2026 |
| Mar 10, 2026 | Thomas T. Vo Chief Executive Officer | MOption exercise Common Stockindirect: See note (4) | +8,334 | $0.00 | $0 | 1,846,213 | Mar 11, 2026 |
| Mar 10, 2026 | Kelvin Spears director | MOption exercise Common Stock | +183 | $0.00 | $0 | 32,209 | Mar 11, 2026 |
| Mar 10, 2026 | Jon Christian Bates Chief Financial Officer | MOption exercise Common Stock | +2,667 | $0.00 | $0 | 8,305 | Mar 11, 2026 |
| Mar 10, 2026 | Michael L. Chang Chief Medical Officer | MOption exercise Common Stockindirect: See note (3) | +2,084 | $0.00 | $0 | 83,125 | Mar 11, 2026 |
| Mar 10, 2026 | Warren Hosseinion President | MOption exercise Common Stock | +6,293 | $0.00 | $0 | 10,787 | Mar 11, 2026 |
| Mar 10, 2026 | Elisa Luqman V Chief Legal Officer - SEC | MOption exercise Common Stockindirect: See note (4) | +2,084 | $0.00 | $0 | 3,154 | Mar 11, 2026 |
| Mar 10, 2026 | Pamela W. Montgomery Chief Legal Officer-Healthcare | MOption exercise Common Stock | +2,084 | $0.00 | $0 | 3,455 | Mar 11, 2026 |
| Mar 10, 2026 | Thomas T. Vo Chief Executive Officer | FTax withholding Common Stockindirect: See note (4) | -3,017 | $86.22 | $260k | 1,843,196 | Mar 11, 2026 |
| Mar 11, 2026 | Jon Christian Bates Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | +1,694 | $0.00 | $0 | 5,527 | Mar 11, 2026 |
| Mar 10, 2026 | Kelvin Spears director | FTax withholding Common Stock | -82 | $86.22 | $7,070 | 32,127 | Mar 11, 2026 |
| Mar 10, 2026 | Michael L. Chang Chief Medical Officer | FTax withholding Common Stockindirect: See note (3) | -769 | $86.22 | $66k | 82,356 | Mar 11, 2026 |
| Mar 10, 2026 | Warren Hosseinion President | FTax withholding Common Stock | -3,274 | $86.22 | $282k | 7,513 | Mar 11, 2026 |
| Mar 10, 2026 | Elisa Luqman V Chief Legal Officer - SEC | FTax withholding Common Stockindirect: See note (4) | -784 | $86.22 | $68k | 2,370 | Mar 11, 2026 |
| Mar 10, 2026 | Pamela W. Montgomery Chief Legal Officer-Healthcare | FTax withholding Common Stock | -776 | $86.22 | $67k | 2,679 | Mar 11, 2026 |
| Mar 10, 2026 | Pamela W. Montgomery Chief Legal Officer-Healthcare | MOption exercise Restricted Stock Unitsderivative | +1,525 | $0.00 | $0 | 5,217 | Mar 11, 2026 |
| Mar 10, 2026 | Thomas T. Vo Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | +4,841 | $0.00 | $0 | 19,524 | Mar 11, 2026 |
| Mar 10, 2026 | Kelvin Spears director | MOption exercise Restricted Stock Unitsderivative | +116 | $0.00 | $0 | 421 | Mar 11, 2026 |
| Mar 10, 2026 | Michael L. Chang Chief Medical Officer | MOption exercise Restricted Stock Unitsderivative | +1,936 | $0.00 | $0 | 5,621 | Mar 11, 2026 |
| Mar 10, 2026 | Warren Hosseinion President | MOption exercise Restricted Stock Unitsderivative | +3,656 | $0.00 | $0 | 15,739 | Mar 11, 2026 |
| Mar 10, 2026 | Elisa Luqman V Chief Legal Officer - SEC | MOption exercise Restricted Stock Unitsderivative | +1,525 | $0.00 | $0 | 4,441 | Mar 11, 2026 |
| Jul 14, 2025 | Cheryl Yvonne Grenas director | AGrant or award Restricted Stock Units (RSUs)derivative | +603 | $0.00 | $0 | 603 | Feb 9, 2026 |
| Jul 14, 2025 | Frank E Jaumot director | AGrant or award Restricted Stock Units (RSUs)derivative | +603 | $0.00 | $0 | 603 | Feb 9, 2026 |
| Jul 14, 2025 | Michael Lee Reed director | AGrant or award Restricted Stock Units (RSUs)derivative | +603 | $0.00 | $0 | 603 | Feb 9, 2026 |
| Jul 14, 2025 | Scott J Saunders director | AGrant or award Restricted Stock Units (RSUs)derivative | +603 | $0.00 | $0 | 603 | Feb 9, 2026 |
| Nov 25, 2025 | Jon Christian Bates Chief Financial Officer | POpen-market purchase Common Stock | +750 | $136.71 | $103k | 5,638 | Nov 28, 2025 |
| Mar 1, 2025 | Warren Hosseinion President | MOption exercise Common Stock | +3,776 | $0.00 | $0 | 4,494 | Apr 14, 2025 |
| Mar 1, 2025 | Joshua DeTillio Chief Operating Officer | MOption exercise Common Stock | +2,125 | $0.00 | $0 | 6,933 | Apr 14, 2025 |
| Mar 1, 2025 | Michael L. Chang Chief Medical Officer | MOption exercise Common Stockindirect: See note (3) | +1,250 | $0.00 | $0 | 81,307 | Apr 14, 2025 |
| Mar 1, 2025 | Jon Christian Bates Chief Financial Officer | MOption exercise Common Stock | +111 | $0.00 | $0 | 2,388 | Apr 14, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Wesley Shane BamburgChief Operating Officer
- Jon Christian BatesChief Financial Officer
- Michael L. ChangChief Medical Officer
- Joshua DeTillioChief Operating Officer
- Cheryl Yvonne Grenasdirector
- Warren HosseinionPresident
- Frank E Jaumotdirector
- Elisa Luqman VChief Legal Officer - SEC
- Pamela W. MontgomeryChief Legal Officer-Healthcare
- Michael Lee Reeddirector
- Scott J Saundersdirector
- Kelvin Spearsdirector
- Thomas T. VoChief Executive Officer
Questions about NUTX
Answered from the filings on this page, as of the latest one.
Are insiders buying NUTX?
As of Sep 18, 2026, SEC Form 4 filings show 0 open-market buys worth $0 by 0 insiders and 1 open-market sell worth $43k by 1 insider at Nutex Health Inc. in the last 90 days, net -$43k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade NUTX on the open market?
Scott J Saunders (director) sold $43k of NUTX on Sep 18, 2026 and filed the Form 4 on Sep 18, 2026. InsiderTell scored 31 (weak).
How many insiders file Form 4 at Nutex Health Inc.?
13 people have filed a Form 4 at Nutex Health Inc., among them Wesley Shane Bamburg (Chief Operating Officer), Jon Christian Bates (Chief Financial Officer), Michael L. Chang (Chief Medical Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.